CP
Collegium Pharmaceutical Inc
🇺🇸XNAS.COLLUnited StatesHealthcare
$22.23USDdown -0.58 (-2.54%)ClosedEnd of day10:57 PM
Price$22.23-0.58 (-2.54%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US19459J1043
- CUSIP
- 19459J104
Company
- Employees
- 423
- Headquarters
- Stoughton, United States
- CEO
- Mr. Vikram Karnani
Market
- Shares outstanding
- 31M
- Market cap
- $689.11M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $689.11M
- EPS LTM
- $1.55calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 14.38calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $808.21M+14.31%up year on year
- Net income
- $47.92M+32.1%up year on year
- Gross margin
- 60.02%+5.88%up year on year
- Free cash flow
- $328.28M+62.67%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.